Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from Northern China

Anticancer Research

Volumn 18, Issue 6 B, 1998, Pages 4667-4672

  Cai, L ^a,b   Wang, G J ^b   Xu, Z L ^b   Deng, D X ^a   Chakrabarti, S ^a   Cherian, M G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Hepatocelluar carcinoma; Metallothionein; Northern Chinese

Indexed keywords

DNA; METALLOTHIONEIN; POLYCLONAL ANTIBODY;

ADULT; AGED; APOPTOSIS; ARTICLE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; METALLOTHIONEIN; MIDDLE AGED;

EID: 0032423811     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cherian MG: MetallothionEin and its interaction with metals. In: Toxicology of Metals Biochemical Aspects (Goyer RA and Cherian MG, eds) Berlin: Springer-Verlag Inc, 1995 pp 121-132.
2. Michalska AE and Choo KH: Targeting and germ-line transmission of a null mutation at the metallothioncin I and II loci in mouse. Proc Natl Acad Sci USA 90: 8088-8092, 1993.
3. Cherian MG and Ferguson P: Metallothionein in cytotoxicity and genotoxiciy of metals. In: Cytotoxic Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human EnviromEnt, NATO ASI Series, 2. Enivrement- Vol. 26 (Hadjiliadis ND, ed.) Dordrecht: Kluwer Academic Publishers, 1997 pp 217-230.
4. Sato M and Bremner I: Oxygen free radicals and metallothionein. Free RadiC Biol Med 14: 325-337, 1993.
5. Cherian MG, Lau JC, Apostolova MD and Cai L: The nuclear-cytoplsmic presence, of metallothionein in cells during differentiation and development. In: Proceeding of MEtallothionein-97 (Klaassen CD, ed.) Basel: Birkhauser Publisher, 1998 in press.
6. Douglas-Jones AG, Schmid RW, Bier B, Horgan K, Lyons K, Dallimore ND, Moneypenny IJ and Jasani B: Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol 26: 217-222, 1995.
7. Goulding H, Jasani B, Pereira H, Reid A, Galca M, Bell JA, Elston CW, Robertson JF, Blarney RW, Nicholson RA, Schmid KW and Ellis IO: Metallothionein expression in human breast cancer. Br J Cancer 72: 968-972, 1995.
8. Oyama T, Take H, Hikino T, Iino Y and Nakajima T: Immunohistochemical expression of metallothioncin in invasive breast cancer in relation to proliferative activity, histology and prognosis, Oncolgy 53: 112-117, 1996.
9. Helal T, Bassiri M and Khalifa A: Immunohistochemical markers of tumour prognosis in breast cancer in Egypt. Cancer Detect Prey 21: 201-206, 1997.
10. Bahnson RR, Becich M, Ernstoff MS, Sandlow J, Cohen MB and Williams RD: Absence of immunohistochemical metallothioncin staining in bladder tumour specimens predicts response to neoadjuyant cisplatin, methotrexate and vinblastine chemotherapy. J Urol 152: 2272-2275, 1994.
11. Nartey N, Cherian MG and Banerjee D: Immunohistochemical localization of metallothionein in human thyroid tumours. Am J Pathol 729; 177-182, 1987.
12. Kontozoglou TE, Banerjee D and Cherian MG: Immunohistochemical localization of metallothioncin in human testicular embryonal carcinoma cells. Virchows Archiv A Pathol Anat Histopathol 45: 545-549, 1989.
13. Chin JL, Banerjee D, Kadhim SA, Kontozoglou -TE, Chauvin PJ and Cherian MG: Metallothionein testicular germ cell tumours and drug resistance. Cancer 72: 3029-3035, 1993.
14. Chauvin PJ, Cherian MG, Wysocki GP and Pringle GA: A comparison of metallothionein expression human normal and neoplastic salivary gland tissue using immunohistochemistry. The Toxicologist 12: 379, 1992.
15. Ohshio G, Imamura T, Okada N, Wang ZH, Yamaki K, Kyogoka T, Suwa H, Yamake H and Imamura M: Immunohistochffnical study of metallothioncin in pancreatic carcinomas. J Cancer Res Clin Oncol 122: 351-355, 1996.
16. Ofner D, Maier II, Riedmann B, Bammer T, Rumff A, Winde G, Bocker W, Jasani B and Schmid KW: Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchow Arch 425: 491-497, 1994.
17. Giuffre G, Barrcsi G, Sturniolo GC, Sarnelli R, D'Lnca R and Tuccari G: Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas, and in adenocarcinomas and their associated metastases. Histopathology 29: 347-354, 1996.
18. Onosaka S, Min KS, Fukuhara C, Tanaka K, Tashiro S-I, Shimizu I, Furuta M, Yasulomi T, Kobashi K and Yamamoto K: Concentration of metallothionein and metals in malignant and non-malignant tissues in human liver. Toxicology 38: 261-268, 1986.
19. Waalkes MP, Diwan BA, Rehm S, Ward JM, Moussa M, Cherian MG and Goyer RA: Down-regulation of metallothionein expression in human and murine hepatocellular tumours: Association with the tumour-necrotizing and antineoplastic effects of cadmium in mice. J Pharmacol Exp Ther 277: 1026-1033 1996.